Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000204119

Medchemexpress LLC Mal-(CH2)5-val-cit-pab-eribulin | 2130869-21-3 | MFCD00051944 | 99.8% | 1328.54 g/mol | C69H97N7O19 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY1396425MG

Encompass_Preferred

Mal-(CH2)5-Val-Cit-PAB-Eribulin is a drug-linker conjugate intended for antibody-drug conjugate (ADC) research that links the anti-microtubule agent eribulin to a cleavable Mal-(CH2)5-Val-Cit-PAB spacer, producing a conjugate with potent antitumor activity for in vitro and preclinical studies.

  • Drug-linker conjugate suitable for ADC research.
  • Contains eribulin linked via a cleavable val-cit-pab spacer.
  • Potent antitumor activity demonstrated in preclinical models.
  • Molecular formula C69H97N7O19; molecular weight 1328.54 g/mol.
  • High purity (99.82%) and supplied in low-milligram quantities for research use.

Catalog No. 50-002-04119


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.